Department of Microbiology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Mol Biol Rep. 2023 Jul;50(7):5565-5574. doi: 10.1007/s11033-023-08476-4. Epub 2023 May 8.
Nosocomial infections (NIs) are a major challenge worldwide. Identification of antibiotic resistance pattern extended spectrum beta-lactamases (ESBLs) and carbapenem-resistant Enterobacteriaceae (CRE) were the objectives of this study.
In this cross-sectional study, the antimicrobial susceptibility pattern of bacterial isolates collected from patients with NIs in ICU was determined. Overall, 42 Escherichia coli and Klebsiella pneumoniae isolates from different infection sites were used to determine phenotypic tests of ESBLs, Metallo-β-lactamases (MBLs) and CRE. Detection of ESBLs, MBLs and CRE genes were performed by the polymerase chain reaction (PCR) method.
From 71 patients with NIs, 103 different bacterial strains were isolated. The most frequently isolated bacteria were E. coli (n = 29; 28.16%), Acinetobacter baumannii (n = 15; 14.56%), and K. pneumoniae (n = 13; 12.26%). Also, the rate of multidrug-resistant (MDR) isolates was 58.25% (60/103). Based on phenotypic confirmation tests, 32 (76.19%) isolates of E. coli and K. pneumoniae produced ESBLs, and 6 (14.28%) isolates were identified as CRE producers. PCR showed the high prevalence of the bla (n = 29; 90.62%) in ESBL genes. In addition, bla was detected in 4 (66.66%), bla in 3 (50%), and bla gene in 1 (16.66%) isolates. The bla, bla, and bla genes were not detected in any of the isolates.
The Gram-negative bacteria E. coli, A. baumannii, and K. pneumoniae with high resistance levels were the most common bacteria causing NIs in the ICU. This study for the first time identified bla, bla, and bla genes in E. coli and K. pneumoniae in Ilam city of Iran.
医院获得性感染(NIs)是全球面临的主要挑战。本研究旨在确定抗生素耐药模式(包括超广谱β-内酰胺酶(ESBLs)和耐碳青霉烯肠杆菌科(CRE))。
在这项横断面研究中,测定了 ICU 中 NIs 患者分离的细菌分离株的抗菌药物敏感性模式。总体而言,从不同感染部位采集了 42 株大肠埃希菌和肺炎克雷伯菌分离株,用于确定 ESBLs、金属β-内酰胺酶(MBLs)和 CRE 的表型试验。通过聚合酶链反应(PCR)方法检测 ESBLs、MBLs 和 CRE 基因。
从 71 例 NIs 患者中分离出 103 株不同的细菌。最常分离的细菌是大肠埃希菌(n=29;28.16%)、鲍曼不动杆菌(n=15;14.56%)和肺炎克雷伯菌(n=13;12.26%)。此外,耐多药(MDR)分离株的发生率为 58.25%(60/103)。基于表型确认试验,32 株(76.19%)大肠埃希菌和肺炎克雷伯菌分离株产生 ESBLs,6 株(14.28%)分离株被鉴定为 CRE 产生者。PCR 显示 ESBL 基因 bla(n=29;90.62%)的高流行率。此外,在 4 株(66.66%)、3 株(50%)和 1 株(16.66%)分离株中检测到 bla、bla 和 bla 基因。在任何分离株中均未检测到 bla、bla 和 bla 基因。
革兰氏阴性菌大肠埃希菌、鲍曼不动杆菌和肺炎克雷伯菌具有较高的耐药水平,是 ICU 中导致 NIs 的最常见细菌。本研究首次在伊朗伊拉姆市鉴定出大肠埃希菌和肺炎克雷伯菌中的 bla、bla 和 bla 基因。